✦ LIBER ✦

A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants

✍ Scribed by David I. Bernstein; Judith Falloon; Tingting Yi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of SC599, an o

✍ Odile Launay; Christine Sadorge; Nathalie Jolly; Béatrice Poirier; Stéphane Béch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 795 KB

A double-blind, placebo-controlled study

✍ Arthur Lyons; Jenice Longfield; Robert Kuschner; Timothy Straight; Leonard Binn; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 187 KB

A multinational, randomized, placebo-con

✍ Robert F. Breiman; W. Abdullah Brooks; Doli Goswami; Rosanna Lagos; Charissa Bor 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 434 KB

Efficacy and safety of an oral live atte

✍ Alexandre C Linhares; F Raúl Velázquez; Irene Pérez-Schael; Xavier Sáez-Llorens; 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 130 KB

Safety and immunogenicity of a vaccine t

✍ Rongcheng Li; Yanping Li; David Radley; Youping Liu; Teng Huang; Heather L. Sing 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 350 KB

Efficacy and safety of a recombinant hep

✍ Feng-Cai Zhu; Jun Zhang; Xue-Feng Zhang; Cheng Zhou; Zhong-Ze Wang; Shou-Jie Hua 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 272 KB